Palto Therapeutics
PrivateCompany Overview
Palto Therapeutics operates in Healthcare & Life Sciences and is based in Allschwil. It was founded in 2020.
Palto Therapeutics is a drug discovery company that develops novel formulations for biological drugs, such as siRNAs, to enable direct and exclusive delivery to diseased cells and tissues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palto Therapeutics Comparables
Compare Palto Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cession Oncology | 84% | |
| Argo Biopharma | 78% | |
| Sirnaomics | 66% |
For institutional investors. Book with your work email.
Palto Therapeutics Funding Rounds
Historical fundraising activity
Palto Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Palto Therapeutics's valuation, stock price, and market status.
Is Palto Therapeutics a public or private company?
Palto Therapeutics is a private company.
What is the current stock price of Palto Therapeutics?
Palto Therapeutics is a private company, so its shares have no public market price. Caplight tracks Palto Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Palto Therapeutics worth (valuation)?
Valuation information for Palto Therapeutics is not publicly available.
Can I buy Palto Therapeutics stock?
Palto Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Palto Therapeutics's last funding round?
Funding round information for Palto Therapeutics is not publicly available.
Who are the main investors in Palto Therapeutics?
Investor information for Palto Therapeutics is not publicly disclosed.
Will Palto Therapeutics IPO soon?
No public IPO plans have been announced for Palto Therapeutics.
How can I track Palto Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Palto Therapeutics's shares on secondary markets.